Form 4: Thermo Fisher Scientific Disposes of Science 37 Holdings Shares at $5.75 Following Reverse Stock Split
SEC Form 4 Filing
Thermo Fisher Scientific and related entities report the disposition of Science 37 Holdings common stock at $5.75 per share following a 1-for-20 reverse stock split.
Summary
- Thermo Fisher Scientific Inc. and affiliated entities, including Pharmaceutical Product Development, LLC, Wildcat Acquisition Holdings (UK) Limited, and others, jointly filed a Form 4 regarding changes in beneficial ownership of Science 37 Holdings, Inc. common stock.
- The filing reports the disposition of 868,990 shares of Science 37 Holdings common stock at a price of $5.75 per share on March 12, 2024.
- The filing is related to a reverse stock split of Science 37 Holdings common stock at a ratio of 1-for-20, which was effected on December 8, 2023.
- The reporting persons may be deemed to constitute a 'group' within the meaning of Section 13(d)(3) of the Securities Exchange Act of 1934.
- Each reporting person disclaims beneficial ownership of the securities reported, except to the extent of its pecuniary interest therein.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing related to a stock transaction, indicating a neutral sentiment.
Industry Context
This filing reflects changes in ownership following a corporate action (reverse stock split) and a subsequent disposition of shares, which is a common occurrence in the life sciences and healthcare technology industries.
Stakeholder Impact
- The disposition of shares may have a minor impact on Science 37 Holdings shareholders.
Key Dates
| Date | Description |
|---|---|
| 2023-12-08 | Science 37 Holdings effected a 1-for-20 reverse stock split. |
| 2024-03-12 | Disposition of Science 37 Holdings common stock at $5.75 per share. |
| 2024-03-14 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.